Perspectives on cognitive domains, H₃ receptor ligands and neurological disease

Bibliography

• CHOONG KC, SHEN RY: Methylphenidate restores ventral tegmental area dopamine neuron activity in prenatal ethanol-exposed rats by augmenting dopamine neurotransmission. Pharmacol Exp. Ther. (2004) 309:444–451.
   PubMed Web of Science ®Google Scholar
• OSTERHELD JR, KOFOED L, TERVO R, FOGAS B, WILSON A, FIECHTNER H: Effectiveness of methylphenidate in Native American children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: A controlled pilot study. Child Adolescent Psychopharmacol (1998) 8:39–48.
   PubMed Web of Science ®Google Scholar
• ROTH BL, SHEFFLER DJ, KROEZE WK: Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nature Rev Drug Disc. (2004) 3:353–359.
   PubMed Web of Science ®Google Scholar
• FERNANDEZ-NOVOA L, CACABELOS R: Histamine (HA) function in brain disorders. Behav. Brain Res. (2001) 124:213–223.
   PubMed Web of Science ®Google Scholar
• •Review of neurotransmitter role of histamine in CNS diseases
   Google Scholar
• PHILIPPU A, PRAST H: Importance of histamine in modulatory processes, locomotion and memory. Behav. Brain Res. (2001) 124:151–159.
   PubMed Web of Science ®Google Scholar
• PHILIPPU A, PRAST H: Role of histaminergic and cholinergic transmission in cognitive processes. Drug News Perspect. (2001) 14:523–529.
   PubMed Web of Science ®Google Scholar
• BACCIOTTINI L, PASSANI MB, MANNAIONI PF, BLANDINA P: Interactions between histaminergic and cholinergic systems in learning and memory. Behav. Brazil Res. (2001) 124:183–194.
   PubMed Web of Science ®Google Scholar
• •Description of proposed pathways by which histaminergic neurons affect other neurotransmitter systems.
   Google Scholar
• MYHRER T: Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res. Rev (2003) 41:268–287.
   PubMed Web of Science ®Google Scholar
• •Review of different neurotransmitter roles in cognitive function
   Google Scholar
• BLANDINA P, EFOUDEBE M, CENNI G, MANNAIONI P, PASSANI MB: Acetylcholine, histamine and cognition: two sides of the same coin. Learn. Mem. (2004) 11:1–8.
   PubMed Web of Science ®Google Scholar
• •Recent review of ACh/histarnine interactions in different behavioural models of learning.
   Google Scholar
• VIGGIANO D, RUOCCO LA, SADILE AG: Dopamine phenotype and behavior in animal models: in relation to attention deficit hyperactivity disorder. Neurosci. Behav. Rev (2003) 27:623–637.
   PubMed Web of Science ®Google Scholar
• HANCOCK AA, FOX GB: Cognitive enhancing effects of drugs that target histamine receptors. In: Cognitive Enhancing Drugs. Milestones M Drug Therapy Buccafusco JJ (Ed.), Birkhäuser Verlag, Basel, Switzerland (2004):97–114.
   Google Scholar
• •Recent review of the effects of several H3 receptor antagonists in models of learning and memory.
   Google Scholar
• HANCOCK AA, ESBENSHADE TA, KRUEGER KM, YAO BB: Genetic and pharmacological aspects of histamine H3 receptor heterogeneity Life Sci. (2003) 73:3043–3072.
   Google Scholar
• •Review of within- and across-species variation in H3 receptors from a molecular biology to pharmacological perspectives.
   Google Scholar
• BURWELL RD, SADDORIS MP, BUCCI DJ, WIIG JA: Corticohippocampal contributions to spatial and contextual learning. Neurosci. (2004) 24:3826–3836.
   PubMed Web of Science ®Google Scholar
• DERE E, DE SOUZA-SILVA MA, TOPIC B, SPIELER RE, HAAS HL, HUSTON JP: Histidine-decarboxylase knockout mice show deficient nonreinforced episodic object memory, improved negatively reinforced water-maze performance, and increased neo-and ventro-striatal dopamine turnover. Learn. Mem. (2003) 10:510–519.
   PubMed Web of Science ®Google Scholar
• •Useful approach to behavioural analysis using mice in which histamine synthesis is impaired.
   Google Scholar
• TURNER DC, CLARK L, DOWSON J, ROBBINS TW, SAHAKIAN BJ: Modafinil improves cognition and response inhibition in attention-deficit/hyperactivity disorder. Biol. Psych. (2004) 55:1031–1040.
   PubMed Web of Science ®Google Scholar
• COWART MD, ALTENBACH RA, BLACK LA, FAGHIH R, ZHAO C, HANCOCK AA: Medicinal chemistry and biological properties of non-imidazole histamine H3 antagonists. In: Mini-Reviews in Medicinal Chemistry R Leurs (Ed.), Bentham Science Publishers, Inc., The Netherlands (2004) 4:997–1010.
   Google Scholar
• MEIER G, APELT J, REICHERT U aL: Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonists. Ear: Pharmaceut. Sci. (2001), 13: 249–259.
   Google Scholar
• MEGURO K, YANAI K, SAKAI N et al: Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice. Pharmacol Biochem. Behav. (1995) 50:321–325.
   PubMed Web of Science ®Google Scholar
• GIOVANNINI MG, BARTOLINI L, BACCIOTTINI L, GRECO L, BLANDINA P: Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia. Behav. Brain Res. (1999) 104:147–155.
   PubMed Web of Science ®Google Scholar
• •Agonist and antagonist interaction studies that provide validation for the role of H3 receptors in cognitive performance.
   Google Scholar
• BLANDINA P, GIORGETTI M, BARTOLINI L et al.: Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br. Pharmacol (1996) 119:1656–1664.
   PubMed Web of Science ®Google Scholar
• TOYOTA H, DUGOVIC C, KOEHL M et al.: Behavioral characterization of mice lacking histamine H(3) receptors. Mol Pharmacol (2002) 62:389–397.
   PubMed Web of Science ®Google Scholar
• ••First report of behavioural activity tests in H3 receptor-knockout mice.
   Google Scholar
• CHEN Z, SHEN YJ: Effects of brain histamine on memory deficit induced by nucleus basalis-lesion in rats. Acta Pharmacol Sin. (2002) 23:66–70.
   PubMed Web of Science ®Google Scholar
• KAMEI C, TASAKA K: Effect of histamine on memory retrieval in old rats. Biol. Pharm. Bull. (1993) 16:128–132.
   PubMed Web of Science ®Google Scholar
• BONGERS G, LEFEVOUR A, ROBERTSON J, RABER J: Role of H3 receptor-mediated signaling in cognition. Inflamm. Rev. (2004) 53: S51–S52.
   PubMed Web of Science ®Google Scholar
• •Alternate view of H3 receptor antagonist role in learning and memory.
   Google Scholar
• BONGERS G, LEURS R, ROBERTSON J, RABER J: Role of H3-receptor-mediated signaling in anxiety and cognition in wild-type and Apo e-1- mice. Neuropsychopharmacol (2004) 29:441–449.
   PubMed Web of Science ®Google Scholar
• •Further studies in the Apoe knockout mice in which H3 antagonists did not enhance object recognition memory.
   Google Scholar
• ONODERA K, MIYAZAKI S, IMAIZUMI M, STARK H, SCHUNACK W: Improvement by FUB 181, a novel histamine H3 receptor antagonist, of learning and memory in the elevated plus-maze test in mice. Naunyn-Schmied. Arch Pharmacol (1998) 357:508–513.
   PubMed Web of Science ®Google Scholar
• MIYAZAKI S, IMAIZUMI M, ONODERA K: Effects of thioperamide, a histamine H3-receptor antagonists, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice. Life Sci. (1995) 57:2137–2144.
   PubMed Web of Science ®Google Scholar
• DECKER MW, CURZON P, BRIONI JD, ARNERIC SP: Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Ear. Pharmacol (1994) 261:217–222.
   PubMed Web of Science ®Google Scholar
• KOMATER VA, BUCKLEY MJ, BROWMAN KE et al.: Effects of histamine H3 receptor antagonists in two models of spatial learning. Behav.Brain Res. (2004) (In Press).
   Google Scholar
• SMITH CP, HUNTER AJ, BENNETT GW: Effects of (R)-a-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze. Psychopharmacology (1994) 114:651–656.
   PubMed Web of Science ®Google Scholar
• RUBIO S, BEGEGA A, SANTIN LJ, ARIAS JL: Improvement of spatial memory by (R)-a-methylhistamine, a histamine H3 receptor agonist, on the Morris water-maze in rat. Behav. Bradt. Res. (2002) 129:77–82.
   PubMed Web of Science ®Google Scholar
• FOX GB, ESBENSHADE TA, PAN JB et al.: Pharmacological properties of ABT-239: II. Neurophysiological characterization and broad preclinical efficacy of a potent and selective histamine H3 receptor antagonist in cognition and schizophrenia. Pharmacol Exp. Ther. (2004) (Submitted).
   Google Scholar
• RIZK A, CURLEY J, ROBERTSON J, RABER J: Anxiety and cognition in histamine H3 receptor-/- mice. Eur: Neurosci. (2004) 19:1992–1996.
   PubMed Web of Science ®Google Scholar
• TERRY AV, HILL WD, PARIKH V, WALLER J L, EVANS DR, MAHADIK SP: Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats. Neuropsychopharmacology (2003) 28:300–309.
   PubMed Web of Science ®Google Scholar
• FOX GB, PAN JB, ESBENSHADE TA et al.: Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup. Behav. Brain Res. (2002) 131:151–161.
   PubMed Web of Science ®Google Scholar
• •Demonstration of strain differences in cognitive performance in rats, with deficits observed in SH rats and an improvement in cognitive and/or attentional skills upon the administration of H3 receptor antagonist.
   Google Scholar
• WILENS TE, BIEDERMAN J, SPENCER TJ et al.: A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Amer. Psych. (1999) 156:1931–1937.
   Google Scholar
• TEDFORD C: Clinical application of histamine H3 receptor antagonists in learning and memory disorders. In: The Histamine H3Receptor. R Leurs, H Timmerman (Eds.), Elsevier, Amsterdam, The Netherlands (1998):269–286.
   Google Scholar
• •Review of effects of several imidazole-based H3 receptor antagonists from Gliatech in a cognition model.
   Google Scholar
• KOMATER VA, BROWMAN KE, CURZON P, HANCOCK AA, DECKER MW, FOX GB: H3 receptor blockade by thioperamide enhances cognition without inducing locomotor sensitization. Psychopharmacology (2003) 167:363–372.
   PubMed Web of Science ®Google Scholar
• •Key differentiation between ancillary pharmacological effects of stimulants contrasted with H3 receptor antagonists, which may have clinical relevance.
   Google Scholar
• FOX GB, PAN JB, RADEK RJ et al.: Twonovel and selective non-imidazole H3 receptor antagonists, A-304121 and A-317920:2, Li vivo behavioral and neurophysiological characterization. Pharmacol Exp. Ther. (2003) 305:897–908.
   PubMed Web of Science ®Google Scholar
• ESBENSHADE TA, FOX GB, KRUEGER KM et al.: Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist. Biochem. Pharmacol (2004) 68:933–945.
   PubMed Web of Science ®Google Scholar
• •Report of a recent example of a non-imidazole H3 receptor antagonist in which potency differences between species are minimal.
   Google Scholar
• FOX GB, PAN JB, KOMATER V et ak Cognition enhancing effects of H3 antagonists in several animal models. Inflamm. Res. (2004) 53:S49–S50.
   PubMed Web of Science ®Google Scholar
• HAHN B, SHOAIB M, STOLERMAN IP: Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands. Psychopharmacology (2002) 162:129–137.
   PubMed Web of Science ®Google Scholar
• LIGNEAU X, UN J, VANNI-MERCIER G et al.: Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. Pharmacol Exp. Ther. (1998) 287:658–666.
   PubMed Web of Science ®Google Scholar
• •Only report, to date, demonstrating pro-cognitive effects of an H3 receptor antagonist in the 5-choice serial reaction time test.
   Google Scholar
• CHEN Z, SUGIMOTO Y, KAMEI C: Effects of intracerebroventricular injection of alpha-fluoromethylhistidine on radial maze performance in rats. PharmacoL Biochem. Behav (1999) 64:513–518.
   PubMed Web of Science ®Google Scholar
• CHEN Z, KAMEI C: Facilitating effects of histamine on spatial memory deficit induced by scopolamine in rats. Acta. Pharmacol Sin. (2000) 21:814–818.
   PubMed Web of Science ®Google Scholar
• •Demonstration of histamine H3 receptor and ACh interactions in cognition based on scopolamine deficits.
   Google Scholar
• CHEN Z: Effect of histamine H3-receptor antagonist clobenpropit on spatial memory of radial maze performance in rats. Acta. Pharmacol Sin. (2000) 21:905–910.
   PubMed Web of Science ®Google Scholar
• HUANG YW, HU WW, CHEN Z et al.: Effect of the histamine H3-antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial maze in Sprague-Dawley rats. Behav. Brain Res. (2004) 151:287–293.
   PubMed Web of Science ®Google Scholar
• •Demonstration of the potential role of H3 receptor antagonists in schizophrenia based on glutarnatergic receptor interactions.
   Google Scholar
• ORSETTI M, FERRETTI C, GAMALERO SR, GHI P: Histamine H3-receptor blockade in the rat nucleus basalis magnocellularis improves place recognition memory. Psychopharmacology (2002) 159:133–137.
   PubMed Web of Science ®Google Scholar
• ORSETTI M, GHI P, DI CARLO G: Histamine H3-receptor antagonism improves memory retention and reverses the cognitive deficit induced by scopolamine in a two trial place recognition task. Behav. Brain Res. (2001) 124:235–242.
   PubMed Web of Science ®Google Scholar
• •Interesting findings of a possible pathway through H2 receptors, unlike most behavioural studies suggesting that H3 receptor blockade increased histamine release and stimulation of postsynaptic H1 receptors.
   Google Scholar
• PRAST H, ARGYRIOU A, PHILIPPU A: Histaminergic neurons facilitate social memory in rats. Brain Res. (1996) 734:316–318.
   PubMed Web of Science ®Google Scholar
• BROWMAN KE, KOMATER VA, CURZON P et al.: Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behav. Brain Res. (2004) 153:69–76.
   PubMed Web of Science ®Google Scholar
• ADLER LE, PACHTMAN E, FRANKS RD, PECEVICH M, WALDO MC, FREEDMAN R: Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol. Psychiatry (1982) 6:639–654.
   Google Scholar
• FREEDMAN R, ADLER LE, GERHARDT GA et al.: Neurobiological studies of sensory gating in schizophrenia. Schizophr. Bull. (1987) 13:669–678.
   PubMed Web of Science ®Google Scholar
• ELLISON, G.: Stimulant-induced psychosis, the dopamine theory of schizophrenia and the habenula. Brain Res. Rev (1994) 19:223–239.
   PubMed Web of Science ®Google Scholar
• MORISSET S, PILON C, TARDIVEL-LACOMBE J et al.: Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D2 and not D3 receptor.' Pharmacol Exp. Ther. (2002) 300:621–628.
   Google Scholar
• VVESTERINK BHC, CREMERS T, DE VRIES JB, LIEFERS H, IRAN N, DE BOER P: Evidence for activation of histamine H3 autoreceptors during handling stress in the prefrontal cortex of the rat. Synapse (2002) 43:238–243.
   PubMed Web of Science ®Google Scholar
• PASSANI MB, CANGIOLI I, BALDI E, BUCHERELLI C, MANNAIONI PF, BLANDINA P: Histamine H3 receptor-mediated impairment of contextual fear conditioning and in-vivo inhibition of cholinergic transmission in the rat basolateral amygdala. Eur. Neurosci. (2001) 14:1522–1532.
   PubMed Web of Science ®Google Scholar
• •Indications of H2 receptor involvement following H3 receptor blockade in another behavioural model.
   Google Scholar
• GIOVANNINI MC, EFOUDEBE M, PASSANI MB et al.: Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells. NeuroscL (2003) 23:9016–9023.
   PubMed Web of Science ®Google Scholar
• •Findings provide a potential signal transduction pathway following blockade of presynaptic H3 receptors.
   Google Scholar
• CANGIOLI I, BALDI E, MANNAIONI PF, BUCHERELLI C, BLANDINA P, PASSANI MB: Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release. Eur. Neurosci. (2002) 16:521–528.
   PubMed Web of Science ®Google Scholar
• ALVAREZ EO, RUARTE MB: Histaminergic neurons of the ventral hippocampus and the baso-lateral amygdala of the rat: functional interaction on memory and learning mechanisms. Behav. Brain Res. (2002) 128:81–90.
   PubMed Web of Science ®Google Scholar
• MIKLOS IH, KOVACS KJ: Functional heterogeneity of the responses of histaminergic neuron subpopulations to various stress challenges. Ear: Neurosci. (2003) 18:3069–3079.
   PubMed Web of Science ®Google Scholar
• ••Key reference indicating the possible heterogeneity of histaminergic neuron populations.
   Google Scholar
• SERGEEVA OA, ERIKSSON KS, HAAS HL: Glycine receptor mediated responses in rat histaminergic neurons. NeuroscL Lett. (2001) 300:5–8.
   PubMed Web of Science ®Google Scholar
• SITTIG N, DAVIDOWA H: Histamine reduces firing and bursting of anterior and intralaminar thalamic neurons and activates striatal cells in anesthetized rats. Behav. Brain Res. (2001) 124:137–143.
   PubMed Web of Science ®Google Scholar
• ALVES-RODRIGUES A, TIMMERMAN H, WILLEMS E, LEMSTRA S, ZUIDERVELD OP, LEURS R: Pharmacological characterisation of the histamine H3 receptor in the rat •• hippocampus. Brain Res. (1998) 788:179–186••Key reference indicating potentialheterogeneity of the control (via H3 receptor blockade) of noradrenaline compared with ACh release.
   Google Scholar
• BACCIOTTINI L, PASSANI MB, GIOVANNELLI L et al.: Endogenous histamine in the medial septum-diagonal band complex increases the release of acetylcholine from the hippocampus: a dual-probe microdialysis study in the freely moving rat. Ear: Neurosci. (2002) 15:1669–1680.
   Google Scholar
• ESBENSHADE TA, KRUEGER KM, MILLER TR et al.: Two novel and selective non-imidazole H3 receptor antagonists, A-304121 and A-317920: I. Li vitro pharmacological effects. J. Phannacol Exp. Ther. (2003) 305:887–896.
   PubMed Web of Science ®Google Scholar
• LIGNEAU, X. MORISSET S, TARDIVEL-LACOMBE J et al.: Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain. Br. J. Pharmacol (2000) 131:1247–1250.
   Google Scholar
• YAO BB, HUTCHINS CW, CARR TL et al.: Molecular modeling and pharmacological analysis of species-related histamine H3 receptor heterogeneity. Neuropharmacol (2003) 44:773–786.
   PubMed Web of Science ®Google Scholar
• •Provides an alternate molecular model of antagonist binding to H3 receptors based on key amino acid changes in rat compared with human.
   Google Scholar
• CHEN J, LIU C, LOVENBERG TW: Molecular and pharmacological characterization of the mouse histamine H3 receptor. Ear: Pharmacol (2003) 467:57–65.
   PubMed Web of Science ®Google Scholar
• YAO BB, SHARMA R, CASSAR S, ESBENSHADE TA, HANCOCK AA: Cloning and pharmacological characterization of the monkey histamine H3 receptor. Ear: Pharmacol (2003) 482:49–60.
   PubMed Web of Science ®Google Scholar
• BAKKER RA, VAN MARLE A, FLORES LOZADA A et al.: Cloning and functional identification of novel rH3 receptor isoforms. 32nd Annual Meeting of The European Histamine Research Socieg,. Noordwijkerhout, The Netherlands (2003) 35.
   Google Scholar
• DRUTEL G, PEITSARO N, KARLSTEDT K et al.: Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Ma Phannacol (2001) 59:1–8.
   Google Scholar
• ••Key pharmacological study of isoforms ofthe rat H3 receptor.
   Google Scholar
• BROWN RE, STEVENS DR, HAAS HL: The physiology of brain histamine. Frog. Neurobiol (2001) 63:637–672.
   Google Scholar
• MORISSET S, ROULEAU A, LIGNEAU X et al.: High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature (2000) 408:860–864.
   PubMed Web of Science ®Google Scholar
• ••Important discovery of the constitutiveactivity of H3 receptors.
   Google Scholar
• WELLENDORPH P, GOODMAN MW, BURSTEIN ES, NASH NR, BRANN MR, WEINER DM:. Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor. Neuropharmacology (2002) 42:929–940.
   Google Scholar
• MORISSET S, SASSE A, GBAHOU F et al.: The rat H3 receptor: gene organization and multiple isoforms. Biochem. Biophys. Res. Comm. (2001) 280:75–80.
   PubMed Web of Science ®Google Scholar
• ROULEAU, A. LIGNEAU X, TARDIVEL-LACOMBE Jet al.: Histamine H3-receptor-mediated [35S]GTPy[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors. Br. J. Pharmacol (2002) 135:383–392.
   Google Scholar
• WIELAND, K, BONGERS G, YAMAMOTO Y et al.: Constitutive activityof histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists. Pharmacol Exp. The]: (2001) 299:908–914.
   Google Scholar
• COGE F, GUENIN SP, AUDINOT V et al.: Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem.j. (2001) 355:279–288.
   PubMed Web of Science ®Google Scholar
• GBAHOU F, ROULEAU A, MORISSET S et al.: Protean agonism at histamine H3 receptors M vitro and in vivo. Proc. Natl. Acad. Sci. USA (2003) 100:11086–11091.
   PubMed Web of Science ®Google Scholar
• ••Key study of the protean agonist propertiesof several H3 receptor ligands.
   Google Scholar
• WULFF BS, HASTRUP S, RIMVALL K: Characteristics of recombinantly expressed rat and human histamine H3 receptors. Ear: Pharmacol (2002) 453:33–41.
   PubMed Web of Science ®Google Scholar
• BARNES W, BOYD D, HOUGH L: Dynamics of histamine H3 receptor antagonists on brain histamine metabolism: do all histamine H3 receptor antagonists act at a single site? Ear: Pharmacol (2001) 431:215–221.
   Google Scholar
• ••Important demonstration of differenteffects on patterns of histamine turnover in the brain following administration of diverse H3 antagonists.
   Google Scholar
• TOZER MJ, KALINDJIAN SB: Histamine H3 receptor antagonists. Expert Opin. Ther. Patents (2000) 10:1045–1055.
   Web of Science ®Google Scholar
• STARK J: Recent advances in histamine H3/H4 receptor ligands. Expert Opin. Patents (2003) 13:851–865.
   Web of Science ®Google Scholar